Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Therapeutic Advances in Medical Oncology|January 5, 2026
Comparison of radiological and pathological tools to assess response to neoadjuvant treatment in resected pancreatic ductal adenocarcinoma patientsAnaïs Jenvrin, Riccardo Sartoris, Safi Dokmak, et al.
The Journal of Pathology|June 10, 2022
Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profileLouis de Mestier, Rémy Nicolle, Nicolas Poté, et al.
Neuroendocrinology|June 26, 2020
Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine NeoplasmsGiovanni Guarneri, Louis de Mestier, Luca Landoni, et al.
Neuroendocrinology|October 8, 2015
Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing SurgerySophie Lardière-Deguelte, Louis de Mestier, François Appéré, et al.
Histopathology|March 27, 2015
High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosisCindy Neuzillet, Anne Couvelard, Annemilaï Tijeras-Raballand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 23, 2022
Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotoninThomas Depoilly, Raffaele Leroux, Dafne Andrade, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 9, 2020
O-positive blood type is associated with prolonged recurrence-free survival following curative resection of pancreatic neuroendocrine tumorsOphélie De Rycke, Anne-Laure Védie, Giovanni Guarneri, et al.
Neuroendocrinology|April 27, 2020
Management and Prognosis of Localized Duodenal Neuroendocrine NeoplasmsServane Gay-Chevallier, Louis de Mestier, Julie Perinel, et al.
Endocrine-Related Cancer|December 3, 2025
Chemoembolization using streptozotocin versus embolization in metastatic NETsAnne-Laure Védie, Francesco Matteini, Jérôme Cros, et al.
Therapeutic Advances in Medical Oncology|April 3, 2023
Efficacy and tolerance of LV5FU2-carboplatin chemotherapy in patients with advanced pancreatic ductal adenocarcinoma after failure of standard regimensThomas Chaigneau, Lina Aguilera Munoz, Caroline Oger, et al.
Pageof 13